Fund shareholders of Protara Therapeutics Inc
ISIN US74365U1079 · United States · LEI 549300VWUGH3220TG273
- Fund shareholders
- 108
- Of which ETFs
- 19 89 other funds
- Value held
- 33.6M $
- Share of capital
- 14.4 % of 59.1M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PROFUND VP ULTRA SMALL CAP ProFunds | 215 | 821.3 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 140 | 534.8 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 130 | 496.6 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 77 | 294.1 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 48 | 223.2 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 44 | 172.5 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 15 | 57.3 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 14 | 65.1 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.20 % | as of Jun 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.16 % | as of May 31, 2026 ↗ |
| Columbia Small Cap Value Discovery Fund COLUMBIA FUNDS SERIES TRUST I | 0.12 % | as of Jul 31, 2026 ↗ |
| Small Cap Value Fund Northern Funds | 0.07 % | as of Jun 30, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 0.05 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.04 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.04 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 0.04 % | as of Jun 30, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 0.04 % | as of May 31, 2026 ↗ |
| NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust | 0.03 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 108 | +9 | 8,507,386 | +28.6 % |
| 2026Q2 | 99 | +14 | 6,613,003 | +35.8 % |
| 2026Q1 | 85 | +12 | 4,869,374 | +14.0 % |
| 2025Q4 | 73 | +13 | 4,270,728 | +9.8 % |
| 2025Q3 | 60 | +35 | 3,891,134 | +100.3 % |
| 2025Q2 | 25 | +8 | 1,942,916 | +19.0 % |
| 2025Q1 | 17 | +6 | 1,632,059 | +60.9 % |
| 2024Q4 | 11 | +1 | 1,014,094 | +85.2 % |
| 2024Q3 | 10 | -2 | 547,562 | -6.5 % |
| 2024Q2 | 12 | +2 | 585,548 | -0.1 % |
| 2024Q1 | 10 | -3 | 586,409 | -2.1 % |
| 2023Q4 | 13 | 599,246 |
Institutional managers
108 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5,207,011 | 27.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,394,968 | 17.7M $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 2,834,652 | 14.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,831,208 | 14.8M $ | as of Mar 31, 2026 |
| Blackstone Inc. | 2,265,514 | 11.8M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 1,969,839 | 10.3M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 1,752,115 | 9.1M $ | as of Mar 31, 2026 |
| Integral Health Asset Management, LLC | 1,750,000 | 9.1M $ | as of Mar 31, 2026 |
| AIGH Capital Management LLC | 1,622,733 | 8.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,402,413 | 7.3M $ | as of Mar 31, 2026 |
| 5AM Venture Management, LLC | 1,369,782 | 7.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,177,200 | 6.1M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,152,714 | 6M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,068,558 | 5.6M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 1,030,846 | 5.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,005,142 | 5.2M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 971,614 | 5.1M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 940,512 | 4.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 925,918 | 4.8M $ | as of Mar 31, 2026 |
| J. Goldman & Co LP | 856,247 | 4.5M $ | as of Mar 31, 2026 |
| Catalio Capital Management, LP | 580,024 | 3M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 567,621 | 3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 556,974 | 2.9M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 531,267 | 2.8M $ | as of Mar 31, 2026 |
| Burkehill Global Management, LP | 450,000 | 2.3M $ | as of Mar 31, 2026 |
Declared shareholders of Protara Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 8.40 % | 4,696,709 | as of Jun 30, 2026 · SCHEDULE 13G |
| Integrated Core Strategies (US) LLC and 3 others | 5.70 % | 3,201,936 | as of Jul 1, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Protara Therapeutics Inc". https://titelia.com/en/stocks/protara-therapeutics-inc-US74365U1079